![Françoise de Craecker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Françoise de Craecker
Directeur/Membre du Conseil chez
X4 PHARMACEUTICALS, INC.
Fortune : 15 047 $ au 30/06/2026
Profil
Françoise de Craecker currently works at Gensight Biologics SA, as Independent Director from 2021, X4 Pharmaceuticals, Inc., as Independent Director from 2021, and Horizon Pharmaceutical LLC, as Senior Vice President & GM-European Operations.
Ms. de Craecker also formerly worked at Raptor Pharmaceuticals Europe BV, as Senior VP, GM-Europe, Middle East & Africa from 2014 to 2017, Novartis Gene Therapies, Inc., as General Manager-Europe Middle East & Africa from 2018 to 2019, and Transkaryotic Therapies, Inc., as Vice President & General Manager-Northern Europe from 2000 to 2014.
Ms. de Craecker received her graduate degree from Katholieke Universiteit Leuven.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/03/2026 | 3 222 ( 0% ) | 15 047 $ | 30/06/2026 |
Postes actifs de Françoise de Craecker
| Sociétés | Poste | Début |
|---|---|---|
| RAPTOR PHARMACEUTICAL CORP | Corporate Officer/Principal | 01/01/2014 |
| GENSIGHT BIOLOGICS S.A. | Directeur/Membre du Conseil | 16/05/2021 |
| X4 PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 14/10/2021 |
Anciens postes connus de Françoise de Craecker
| Sociétés | Poste | Fin |
|---|---|---|
| AVEXIS INC | Corporate Officer/Principal | 01/08/2019 |
Raptor Pharmaceuticals Europe BV
 Raptor Pharmaceuticals Europe BV Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development in other physical and natural sciences | Corporate Officer/Principal | 01/12/2017 |
Transkaryotic Therapies, Inc.
 Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets biopharmaceutical products | Corporate Officer/Principal | 01/03/2014 |
Formation de Françoise de Craecker
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
38
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets biopharmaceutical products | Commercial Services |
Katholieke Universiteit Leuven
 Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Horizon Pharmaceutical LLC
 Horizon Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of life-altering therapeutics that treat debilitating and often fatal diseases | Health Technology |
Gensight Biologics SA
 Gensight Biologics SA Pharmaceuticals: MajorHealth Technology Manufactures and markets novel therapies for severe retinal neurodegenerative diseases | Health Technology |
Raptor Pharmaceuticals Europe BV
Raptor Pharmaceuticals Europe BV Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development in other physical and natural sciences | Commercial Services |
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage gene therapy company | Health Technology |
X4 Pharmaceuticals, Inc.
 X4 Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
